UNIVEST FINANCIAL Increases Stake in Intuitive Surgical by 13.3%

UNIVEST FINANCIAL Corp has expanded its investment in Intuitive Surgical, Inc. (NASDAQ: ISRG) by acquiring an additional 1,028 shares during the third quarter of 2023, increasing its holdings by 13.3%. As a result, the firm now owns 8,784 shares of the medical equipment manufacturer, valued at approximately $3.93 million, according to its recent filing with the Securities and Exchange Commission (SEC).

A range of other institutional investors have also adjusted their positions in Intuitive Surgical. For instance, Vertex Planning Partners LLC raised its stake by 2.3% in the second quarter, bringing its total to 917 shares worth about $498,000. Accredited Investors Inc. increased its position by 2.0% in the third quarter and holds 1,060 shares valued at $474,000.

City Holding Co. made a notable increase of 16.1% in its stake during the second quarter, now owning 159 shares valued at $86,000, while True Vision MN LLC and Evermay Wealth Management LLC also reported increases in their holdings. Currently, approximately 83.64% of Intuitive Surgical’s stock is owned by hedge funds and institutional investors.

Recent Performance and Insider Trading

Intuitive Surgical’s financial performance continues to impress. The company recently announced its earnings results for the fourth quarter, reporting earnings of $2.53 per share, exceeding analysts’ expectations of $2.27 by $0.26. The firm generated $2.87 billion in revenue for the quarter, surpassing forecasts of $2.72 billion, marking an 18.8% increase compared to the same period last year.

In terms of insider trading, significant transactions have occurred recently. Senior Vice President Mark Brosius sold 464 shares on December 15, 2023, at an average price of $548.49, amounting to a total of $254,499.36. Following this sale, Brosius’s stake fell to 131 shares, valued at around $71,852.19. In a larger transaction, Gary S. Guthart, another insider, sold 22,806 shares on December 1, 2023, for a total value of approximately $13.02 million. Following these transactions, only 0.70% of the stock remains under insider ownership.

Analyst Ratings and Future Outlook

Market analysts have recently issued varying ratings for Intuitive Surgical. Sanford C. Bernstein has raised its target price from $740.00 to $750.00, maintaining an “outperform” rating. HSBC Global Research upgraded the stock to “strong-buy,” while Raymond James Financial set a target price of $603.00 with an “outperform” rating.

Overall, the consensus rating for Intuitive Surgical stands at “Moderate Buy,” with a price target averaging $622.58. Analysts expect the company to post earnings per share of $6.43 for the current fiscal year, indicating a positive outlook for its continued growth.

Established in 1995, Intuitive Surgical, headquartered in Sunnyvale, California, specializes in the design and manufacture of robotic-assisted surgical systems, notably renowned for its da Vinci surgical systems. These systems facilitate minimally invasive procedures, translating a surgeon’s hand movements into precise actions of small instruments inside the patient. The company’s operations encompass a range of technologies aimed at enhancing surgical precision and patient outcomes, marking it as a key player in the medical technology sector.

For those interested in further developments, HoldingsChannel.com provides up-to-date information on hedge fund activities and insider trades related to Intuitive Surgical, ensuring investors remain informed on potential market movements.